Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Today the biggest volume day since February!
Summary
2019 was the best year of corporate progress that Lexaria has ever experienced. We started the year with a major announcement with one of the world’s largest companies evaluating our technology, including a negotiated royalty fee applicable to world-wide sales of products utilizing DehydraTECH: our biggest licensing deal ever. We hope to announce ongoing progress with this relationship early in 2020, and we also hope to attract new Fortune 500 CPG licensees in the coming year as well.
Through a partner, we opened a new US facility capable of manufacturing at a potential current rate of up to 200,000 servings of enhanced DehydraTECH powders per day, and we expect this to begin generating licensing as well as fee-for-goods and services revenues for us in early 2020. We signed new corporate clients in the cannabinoid sector throughout the year, many of whom expect to commence retail operations in 2020, and we are increasingly attracting the interest of larger, more established MSOs in the field.
We received approval from Health Canada to open and operate our new cannabis R&D facility in our head office newly-built in Kelowna, Canada, through which we intend to continue to broaden our formulation and IP development and increasingly attract Canadian DehydraTECH licensees with the recent dawn of the legal edibles sector in Canada.
We received our first medical claim patent grants, opening the door to increased likelihood of pharmaceutical operations to come. Lexaria continues to develop its proprietary drug delivery platform and is working on commercial release of DehydraTECH version 2.0 sometime in 2020 with even faster delivery than ever before.
We continue to face headwinds that we need to overcome. We need to evidence wider adoption of our technology within the cannabinoid industries. We also need to provide evidence to the investing public that Lexaria is not a cannabis production company but instead should be distinguished and valued as a leading biotech company with a patented, proprietary drug delivery technology with applications to many industries.
Lexaria expects strong, sustainable revenue growth in 2020 and beyond. We are working towards an application for a national stock exchange listing; hoping to announce additional Fortune-500 relationships; and significant new client relationships.
We are working diligently so that, when we look back on 2020 we remember it only as, “It was the best of times…”
Of course, Lexaria has been working with Canada's National Research Council on DehydraTECH since Feb. 2017.
https://www.lexariabioscience.com/news/lexaria-bioscience-completes-initial-project-with-canadas-national-research-council/
This and the fact that Altria nominated Brian Quigley to Lexaria's BOD help keep me invested.
https://www.lexariabioscience.com/news/lexarias-appoints-former-altria-group-senior-executive-and-operating-company-chief-to-board-of-directors/
I like that Canada National Research Council + Lexaria + Altria = ?
"Lexaria’s workgroup, including extensive ongoing R&D performed by Canada’s National Research Council on our behalf, continues to work closely with Altria to determine appropriateness of the DehydraTECH technology for potential use in the global tobacco industry, via several product formats currently under investigation. Lexaria is making important, significant progress in its goal of achieving reduced-risk methods of nicotine delivery."
Nothing about what they did to increase shareholders' values? LOL
Remember Lexaria's laboratory is licensed and inspected by Health Canada.
https://www.lexariabioscience.com/news/lexaria-bioscience-receives-cannabis-rd-license-from-health-canada/
0 Shares traded in The Great White North!
My God! That lunchroom is just stunning! I'm going all-in now. LOL
This tech. has been around for a while it was first patented in 2015 and studies were conducted prior, I can't find any reference to it being used with any other substance than curcumin, so I doubt if it's a real competitor to us.
https://vs-corp.com/longvida-optimized-curcumin-receives-us-patent-9192644/
Their Curcumin compound does have some real health benefits though: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518252/
The tech. seems like it might be competitive.
Another CBD powder. This one is made with an isolate and they seem to have a problem with bitterness.
https://www.foodnavigator-usa.com/Article/2019/12/12/Caliper-CBD-CEO-Cut-off-between-drugs-and-food-for-CBD-should-be-around-dosage-not-isolate-vs-extract?fbclid=IwAR1GRS-XVQYZIwLgA3vSgZZRf2TcXXnmQfeb55J8WuoQhlLkpuugvaR-KXg
Yeah really, ChrgD+ plus only launched 3 months ago and he wants to know why there hasn't been a surge in sales? They haven't even had time to tally one quarter of sales yet.
Hill Street Reports FQ1 2020 Results
Toronto, Ontario--(Newsfile Corp. - November 28, 2019) - Hill Street Beverage Company Inc. (TSXV: BEER) ("Hill Street" or "the Company") reported its fiscal Q1 2020 financial results for the three-month period ended September 30, 2019. A complete set of financial statements and Management's Discussion & Analysis has been filed at www.sedar.com. All dollar figures are quoted in Canadian dollars.
FQ1 2020 Financial Highlights
• Distributor Sell-In to Retail customers was +5% vs same period year ago.
• Gross Margin on Revenues of $514K improved from 27% to 35% vs same period year ago due to product mix and positive foreign exchange.
• Net loss of $1.5M compared to a net loss of $1.2M in FQ1 2018 driven by several one-time expenses associated with entering the cannabis vertical.
• End of quarter cash position of $204K, no debt, and positive working capital of $0.6M.
"Hill Street has made major strides in building both our brand and distribution for our alcohol-free products over the past two years, and the increase in sell-through to retail is an excellent indicator of our progress. The company has continued to move forward with our plans to enter the Cannabis 2.0 market in spite of the headwinds of the capital markets, major missteps made by billion-dollar cannabis companies, and the overall downturn in the sector, with excellent preparation and analysis for the launch of infused cannabis beverages in 2020," said Terry Donnelly, Hill Street Beverage Co.'s Chairman & CEO. "Our team has taken these challenges in stride, and continues to punch above their weight, with excellent response from retailers for our holiday gift pack and trade promotion for the coming season."
Results of FQ3 2019 Operations
Results for the Period Ended Quarter Ended
September 30, 2019 Quarter Ended
September 30, 2018
Gross Revenue $ 513,766 $ 793,867
Chargebacks, finance fees, and listing fees $ 184,327 $ 282,260
Net Revenue $ 329,439 $ 511,607
Direct Costs $ 152,036 $ 294,613
Gross profit $ 177,403 $ 216,994
Operating Expenses $ 1,002,158 $ 886,829
Other One-time Expenses $ 545,850 $ 304,675
Non Cash Expenses $ 154,982 $ 221,286
Loss before other Income (Expense) $ 1,525,587 $ 1,195,796
Other income (Expenses)
Charges related to RTO $ 0 $ 918,345
Fo reign exchange gain (loss) $ 12,324 $ (14,888 )
Write-off of inventory $ 0 $ (8,007 )
Write-off of intangibles $ 8,000 $ 0
Other Income $ 0 $ 2,640
Loss and comprehensive loss for the period $ 1,545,911 $ 2,134,396
Basic and diluted loss per common share $ 0.02 $ 0.03
Weighted average number of common shares outstanding 96,845,070 64,157,068
Q1 F2020 Operational Highlights
• Hill Street's planned acquisition of OneLeaf Cannabis was mutually terminated on September 30, 2019. Acquisition cost, higher than expected capital expenditures to bring the facility online and lack of clarity from Health Canada concerning the timing of One Leaf's licence grant contributed to the mutual decision.
• Hill Street continued to be active in both Industry and Capital markets investor events:
o Keynote speaker at the inaugural Cannabis Drinks Expo in San Francisco;
o Presented at the Micro Cap Investor conference in NYC, which focused on cannabis edibles;
o Keynote at McGill Centre for Cannabis Research;
o Presented at Extraordinary Futures Conference in Vancouver;
o Presented at the Thinking Capital Conference in Toronto;
o Presenting Sponsor at O'Cannabiz in Niagara Falls.
• Alcohol-free Holiday commitments to the promotional "Entertainers Pack" increased 300% versus same period year ago.
• Fortinos, a large format Retailer with 23 stores in Southern Ontario owned by Loblaws Companies Limited, agreed to list all seven (7) stock-keeping-units ("SKU's") of Hill Street's Vin(Zero) wine and Craft beer. The on-shelf date is October 2019, in time for the important holiday period.
• Five (5) Hill Street SKU's are now available for immediate orders on Amazon.ca.
"I'm delighted to see more retail accounts in more regions embrace the promotion. This beautiful designed mix-pack of red, white and sparkling brut is the perfect compliment for entertaining this holiday season," said Doug Taylor, Chief Commercial Officer.
Highlights Subsequent to September 30, 2019
• Hill Street has begun negotiations with several co-packing partners across Canada to produce its cannabis-infused products, including its award-winning alcohol-free wine and beer. On November 12, 2019, the company announced its first co-packing agreement with Peak Processing Solutions of Windsor, Ontario. Additional co-packing agreements are expected to be announced in due course.
For further information:
Press only:
Terry Donnelly, Chairman, and CEO, Hill Street Beverage Company Inc.,
terry@hillstreetbevco.com, (416) 543-4904;
Investors:
Sean Peasgood, Investor Relations,
sean@sophiccapital.com, (647) 797-0219
About Hill Street Beverage Company Inc. (TSXV: BEER)
Hill Street Beverage Company is the world's most award-winning company exclusively focused on alcohol-free beer, wine, and adult format beverages. Hill Street's great-tasting alcohol free products include Hill Street Craft Brewed Lager, Designated Draf t Pilsner beer, Vin(Zero) and Vintense wines. All have won numerous medals and accolades including three Gold, two Silver, and two Bronze Medals at the U.S. Open Beer Championships, the Retail Council of Canada's Grand Prix award, and a prestigious Double Gold Medal at the San Francisco International Wine Challenge. Hill Street will also produce and sell cannabis-infused adult beverages shortly after edibles becomes legal in Canada, expected to occur on October 17, 2019. Check out Hill Street's award-winning line-up and order product to be delivered straight to your home at www.hillstreetbeverages.com.
I'm jealous. I can't order from the Canadian company that I'm invested in because I'm Canadian and it doesn't look like it will be available in Canada anytime soon, as far as I know, Lexaria has not yet applied to Health Canada for a permit to sell either one of these products here and it takes at least 60 days to get a permit.
Lexaria closes $699,410 (U.S.) tranche of placement
2019-11-14 07:26 ET - News Release
Mr. Alex Blanchard reports
LEXARIA ANNOUNCES CLOSING OF NON-BROKERED PRIVATE PLACEMENT
Lexaria Bioscience Corp. has closed the first tranche of its previously announced private placement of units as at Nov. 13, 2019.
Pursuant to the company's news release of Oct. 30, 2019, the company announces that it has closed this tranche of its offering and has received gross proceeds of $699,410.25 (U.S.) from the sale of an aggregate 1,554,245 units at a price of 45 U.S. cents per unit. Each unit comprises one common share and one share purchase warrant whereby the holder of a warrant will be entitled to exercise the warrant to purchase an additional share at a price of 80 U.S. cents until Nov. 13, 2020, and thereafter at a price of $1.20 (U.S.) until Nov. 13, 2021. The warrants will expire and will no longer be exercisable after the expiry date.
The company also paid $3,937.50 (U.S.) and issued 8,750 warrants to certain finders in connection with the investment by investors of an aggregate 125,000 units. The broker warrants have the same exercise terms and expiry date as the warrants.
The net proceeds received from the offering will be used as to $200,000 (U.S.) for continued research and development of the issuer's DehydraTECH technology; $50,000 (U.S.) for sales and marketing of the issuer's products; $50,000 (U.S.) for finance and legal fees; $75,000 (U.S.) for pursuing patent applications; $170,000 (U.S.) for general working capital; and $150,000 (U.S.) for administration costs.
About Lexaria Bioscience Corp.
Lexaria Bioscience is a global innovator in drug delivery platforms. Its patented DehydraTECH drug delivery technology changes the way active pharmaceutical ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules.
We seek Safe Harbor.
© 2019 Canjex Publishing Ltd. All rights reserved.
Yes, great IP and also don't forget the extensive safety testing.
https://www.lexariabioscience.com/news/lexaria-bioscience-completes-initial-project-with-canadas-national-research-council/
Expect to hear from this lady soon...
https://www.cowen.com/profile/vivien-azer/
Ho, Hum and yawn, the market doesn't care!
"Cowen cannabis and alcoholic beverage analyst Viven Azer said the U.S. market for cannabis drinks is small, fragmented, and without a clear leader. That’s the case, she said, because early products in states where cannabis sales are legal get people stoned for a long time, and lack consistent intensity, onset, and offset for the high users feel. They’re also expensive, she added."
https://ca.finance.yahoo.com/news/pot-drinks-for-newbies-canopy-growth-strategy-172628533.html?soc_src=social-sh&soc_trk=tw
I agree with you about the competition aspect. My thoughts are that what's probably holding up the advancement of the nicotine product is Shelf Stability testing. Altria doesn't want to market a product that may break down after a short period of time. They have to be able to put a best before date on their product and be confident that it will be stable until after that date. This testing, of course, takes time.
Sounds legit to me Abundance, Hill Street is just about out of cash they need financing, but I don't think Lexaria would be participating in that financing when they need cash to keep their own lights on.
I think something is up though, and I believe they may have something to announce in the morning. Like I said very unusual to announce a dilutive financing mid-week. Fingers are crossed. JMHO
Why the heck didn't Lexaria ask it's existing shareholders to participate in their financing?
This financing must have been negotiated about 3 weeks ago when the issue price would have been at a slight discount to the market price, not the 25% it is now.
I find the timing of this financing announcement a bit strange, these dilutive financings are almost always announced on a Friday to reduce the impact on the share price.
So why announce this on Wednesday, are they clearing the decks for another announcement this week?
Yes, it's pretty disappointing that they could only do a financing at a 25% discount to the market. It also tells us that they don't expect the remaining 11 million dollars to come from Altria any time soon.
It pretty much discounts the possibility of an imminent deal with a large LP or a major beverage company also. This is something that has always bothered me about Lexaria. If their tech is as good as they say why has no LP or beverage company ever been interested in a deal with Lexaria?
From what I understand emulsification and nano infusion of cannabis oils into a beverage or edible is not patentable because this is a common food industry technique to dissolve various oils in liquids.
This may be partly why Linton was fired from Canopy. He paid big bucks for EBBU because they ostensibly had a broad IP portfolio. It's not IP if you can't get a patent.
I posted this back in 2018.
"Ebbu uses nano-technology for their HydroPS cannabis infusion technology. What do they use for the emulsifier? A chemical or is it natural? No one knows!
https://extractionmagazine.com/category/applied-technology/ebbu-hydrops-system-soluble-cannabinoids/
Canopy Growth is using Ebbu's tech. to infuse the beverages that they announced today, but has Ebbu ever actually had a patent awarded? I can't find any reference to any patents, just many patents pending, and numerous rejections of patents. Perhaps we have a slight advantage here by having more intellectual property!
https://www.pressreader.com/canada/toronto-star/20190916/281711206353625
The Competition- they even have a product similar to ChrgD+
https://www.bnnbloomberg.ca/canopy-expects-new-cannabis-products-to-hit-shelves-in-late-2019-1.1339480
OK, Hill Street will be late to the market, and any revenue from license fees to Lexaria will be delayed. Will Lexaria become a market maker eventually? I hope so, but it's going to be a tough slog against an integrated producer like Canopy. They grow the bud, extract, infuse, bottle and market all in-house and they don't have to pay license fees for their infusion tech. It's going to be hard to compete on costs. Canopy also claims great taste, quick onset-offset, precise dosing and low-calorie products. Are they better? I don't know, I'd have to try each.
I'm also a shareholder (disappointed) in BEER.
Canopy Growth just showcased its line up of infused drinks on Bloomberg BNN. A large selection of both canned and bottled drinks was presented which should be available in Canada by late December. I'll find the link later.
We're going to be late to market and have to fight the big boys for a small piece of an established market! JMHO!
In all fairness "killing themselves" is a pretty extreme description for what is happening. They are not killing themselves but limiting any upside move in the stock price, but botching the legalization of edibles/infusible products in Canada.
It could all become a moot point if they announce tomorrow that Altria is advancing with the nicotine project. Altria could also announce that the results didn't meet their expectations and that could send the share price plummeting.
Definitely ChrgD+, Turbo CBD and Vipova are on the market in the US, but at this time, I don't believe that you can import any of these products into Canada.
I've been invested in Lexaria for over 5 years and have a fairly substantial position and I've also done in depth due diligence on this company, thankyou. Everything I've said is true so if you don't like contrary opinions please ignore me because I will always discuss both the pros and cons of this stock.
In order to have an infused beverage or powder/capsule on the market in Canada by the start date of Dec. 17, 2019, a company would have had to of applied to Health Canada on Oct 17. Health Canada has to inspect the manufacturing facility and approve the product. Of course Hill Street or Lexaria could announce tomorrow that they have acquired a bottling and or powder manufacturing facility and that they are submitting their products for approval, doubtfull. Large LP's in Canada are set to flood the market with infused edibles and beverages come Dec 17, so when Lexy finally comes to market (late) we will be fighting to grab a small piece of an already established market. Of course, we still have Cannfections so there should be some revenue there.
It was all supposed to be manufactured at Oneleaf's facility in Regina and Hill Street's takeover of that company is kaput!
Lexaria killing themselves. No infused beverages will available for sale in Canada by Dec 17 and no powders such as cannabis and/or CBD (cannabidiol) hemp powder for new consumer products including among other categories: tablets, capsules or packets for sale in Canada and for export as Hill Street was planning on manufacturing these products at the Oneleaf facility.
Sad.
BEER a NOTHING UPDATE-NO MONEY/NO BOTTLING PLANT for CANNABIS?
ORIGINAL: Hill Street Reports FY2019 Year End Results & Provides Update on Operations
2019-10-29 08:53 ET - News Release
Toronto, Ontario--(Newsfile Corp. - October 29, 2019) - Hill Street Beverage Company Inc. (TSXV: BEER) ("Hill Street" or the "Company") reported its fiscal 2019 financial results for the twelve-month period ended June 30, 2018. A complete set of financial statements and Management's Discussion & Analysis has been filed at www.sedar.com. All dollar figures are quoted in Canadian dollars.
FY2019 Year End Financial Highlights
Gross revenue of $2.432 million, up 61% y/y;
Gross profit of $0.432 million up 400% y/y;
Gross profit of 18% of gross revenue up from 6% year ago;
Net loss of $5.944 million, including the following one-time and non cash charges:
$0.918 million charge for the public company listing;
$0.826 million for Stock based compensation; and
$.869 million in professional fees
Working capital of $1.880 million, compared with $1.455 million for same period last year;
End of quarter cash position of $1.068 million, with no debt.
"With cannabis edibles legal earlier this month in Canada, Hill Street continues to grow its brand awareness and consumer offtake in the alcohol free beverage segment," said Terry Donnelly, CEO of Hill Street. "All of the alcohol free revenue earned during the year came from growing our retail and distribution channels. Operational improvements made in FY18 began to show the results we anticipated. Going forward to address the cannabis-infused edibles market, we are evaluating companies third-party bottling and canning companies that have facilities designed and licensed to produce cannabis beverages remain. We are confident that Hill Street's alcohol free and cannabis infused business model will materialize as expected over the next 12 months."
Results for the Year Ended
June 30, 2019 June 30, 2018
Gross Revenue $2,432,094 $1,511,311
Chargebacks and listing fees -$1,151,894 -$840,429
Net Revenue $1,280,200 $670,882
Direct Costs -$848,373 -$584,500
Gross profit $431,827 $86,382
Operating Expenses $3,697,557 $2,126,109
Other One-time Expenses $868,984 $148,220
Non Cash Expenses $875,666 $895
Loss before other Income (Expense) -$5,010,380 -$2,188,842
Other income (Expenses)
Foreign exchange (loss) gain -$17,240 -$709
Loss on legal settlement -$215,930
Write-off of inventory -$7,298 -$242,399
Write-off of equipment -6,936
Write-off accounts payable
Charges relating to public company listing -$918,345
Other Income $9,411 $1,830
Income (Loss) and comprehensive Income (loss) for the period -$5,943,852 -$2,652,986
Basic and diluted income (loss) per common share -$0.07 -$0.07
Weighted average number of common shares outstanding 85,543,433 40,229,986
The Company presently has one business segment, the marketing and distribution of alcohol-free beer and wine in Canada and, to a much lesser extent, the United States. Hill Street sells its products online and into approximately 10,000 points of distribution in retail large chain stores in Canada. Hill Street's investment in it Distributor/ Broker networks has resulted in significant new distribution and retail listings. It also provides a direct consumer subscription service at www.hillstreetbevco.com.
Non-Alcoholic Adult Beverages
According to a leading beverage industry market research firm1, the non-alcoholic wine and beer market consistently ranks as one of the fastest growing sectors in the global beverage industry and is expected to generate 8.5% CAGR globally until 2025. In Canada, the segment has experienced annual growth in excess of 20% a year for the past few years, which has seen the launch of new alcohol-free beer brands from the top brewers in the world, in addition to new craft beer offerings from regional and local brewers. Hill Street has acquired a significant part of this growth, leveraging our relationship with major national retailers to expand our presence on shelf, as well as securing the opportunity to produce private label versions of our products for major retailers.
Cannabis-infused Adult Beverages
According to Statistics Canada, there are approximately 20 million consumers who drink alcohol. Per capita, the Canadian consumer drank approximately 255 (371 ml size) bottles per capita in 2015, implying that more than 5 billion bottles of beer were consumed during that year. The annual decline of beer consumption in Canada is 0.7%, as consumers trend to moderation and look for alternatives to alcohol given its negative impact on their health and lifestyle.
Since regulations prohibit the mixing of alcohol and cannabis in a commercial product, a beverage must contain no alcohol if cannabis is to be added to it, and the removal of alcohol from traditional beer and wine changes the flavour profile of the beverage. For this reason, any producer of traditional alcoholic beer or wine wishing to create a cannabis-infused version of its products would first have to produce great tasting alcohol-free versions of their brands that consumers would enjoy. Having already solved this problem, Hill Street is proceeding on to the next stage-infusing its beverages with cannabis. Management's license agreement with Lexaria Bioscience , provides the Company with access to technology to render cannabis into an odorless and tasteless water-soluble powder which can then be added to its alcohol-free beverages.
Hill Street believes that the cannabis-infused beverage segment can best be described as three distinct beverage categories: 1) "Heighten" (adult recreational use); 2) "Help" (therapeutic or functional beverages); and 3) "Heal" (beverages) and medicinal or prescription beverages). We intend to produce, market and sell beverages for the adult use and therapeutic or functional beverage categories.
Hill Street intends to meet this potential demand with the same type of high quality and award-winning products we have produced for the alcohol-free category, and with the same level of focus on brand development, sales and distribution.
About Hill Street Beverage Company Inc. (TSXV: BEER)
Founded in 2008, Hill Street Beverage Company is the world's most award-winning company exclusively focused on alcohol-free beer, wine, and adult format beverages. Hill Street products include: Hill Street Craft Brewed Lager, Designated Draft alcohol-free beer, Vin(Zero) wines, and Vintense wines. Hill Street's award-winning products have won the Retail Council of Canada's Grand Prix, and numerous medals and accolades including three Gold, two Silver, and two Bronze Medals at the U.S. Open Beer Championships, and a prestigious Double Gold Medal at the San Francisco International Wine Challenge. As a result of the Royal Assent of Canada's Bill C-45, legislation to allow the sale of cannabis-infused beverages is expected to occur by October 17, 2019. Hill Street is currently applying for appropriate licenses to permit the production and sale of cannabis infused beverages in Canada, with the view of having infused products available for sale once the regulations permit. www.hillstreetbeverages.com
1 Mintel, Global Food and Drink Trends, 2019
They should put more lines in the water or change the bait.